
Exploiting the immune landscape of HOXA9/WNT6-driven glioblastoma: opportunities for novel precision therapies
Glioblastoma (GBM) is a notoriously devastating malignant brain tumor, presenting remarkable intratumor heterogeneity. Despite aggressive treatments, it is universally fatal, with a median patient survival of…